Fate Therapeutics, Inc. (FATE) NASDAQ
2.57
-0.17(-6.20%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.57
-0.17(-6.20%)
Currency In USD
| Market Cap | 116.72M |
| Enterprise Value | 147.94M |
| P/E Ratio | -2.37 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 47.43 |
| Price/Book Ratio | 1.72 |
| Enterprise/Revenue | 53.32 |
| Enterprise/EBITDA | -2.77 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -20.57 |
| Operating Margin | -22.07 |
| Return On Assets | -0.46 |
| Return On Equity | -0.59 |
| Revenue | 6.65M |
| Revenue/Share | 0.05 |
| Gross Profit | -6.26M |
| EBITDA | -127.02M |
| Net Income | -136.32M |
| Diluted EPS | -1.15 |
| Total Cash | 174.82M |
| Total Cash/Share | 1.46 |
| Total Debt | 76.79M |
| Total Debt/Equity | 0.43 |
| Current Ratio | 5.85 |
| Book Value Per Share | 1.5 |
| 52-Week Change | 97.69 |
| 52-Week High | 2.88 |
| 52-Week Low | 0.91 |
| Moving Average 50 Days | 1.64 |
| Moving Average 200 Days | 1.29 |
| Average Volume | 2.61M |
| Shares Outstanding | 116.56M |
| % Held by Institutions | 62.37 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |